Last kr4.21 SEK
Change Today -0.16 / -3.66%
Volume 13.0K
HMED On Other Exchanges
Symbol
Exchange
Stockholm
As of 12:00 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

hansa medical research ab (HMED) Snapshot

Open
kr4.37
Previous Close
kr4.37
Day High
kr4.37
Day Low
kr4.21
52 Week High
12/18/12 - kr5.90
52 Week Low
10/23/12 - kr2.42
Market Cap
93.6M
Average Volume 10 Days
10.6K
EPS TTM
kr-1.19
Shares Outstanding
22.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HANSA MEDICAL RESEARCH AB (HMED)

Related News

No related news articles were found.

hansa medical research ab (HMED) Related Businessweek News

No Related Businessweek News Found

hansa medical research ab (HMED) Details

Hansa Medical AB operates as a biotechnology research and development company that focuses on the treatment and diagnosis of inflammation. It is developing two preclinical biopharmaceutical programs, including anti-alpha-11 for the treatment of rheumatoid arthritis; and IdeS for treatment in connection with organ transplantation. The company is also developing a clinical-stage diagnostic method, HMD-301, for the prognosis and diagnosis of severe sepsis. Hansa Medical AB has collaboration agreements with Axis-Shield plc to develop Heparin Binding Protein as a biomarker for severe sepsis; and Inverness Medical Innovations Inc. and Biosite Inc. to develop anti-alpha-11 antibodies. The company was founded in 2001 and is based in Lund, Sweden.

Founded in 2001

hansa medical research ab (HMED) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hansa medical research ab (HMED) Key Developments

Hansa Medical AB Reports Group Earnings Results for the Year 2012

Hansa Medical AB reported group earnings results for the year 2012. For the year, the company's net sales were SEK 2.6 million compared with SEK 1.3 million a year ago. The group’s net loss was SEK 16.5 million compared with SEK 24.6 million a year ago. Operating loss for the group amounted to SEK 16.8 million compared with SEK 24.5 million a year ago. Loss per share was SEK 0.78 compared with SEK 2.26 a year ago.

Hansa Medical AB, Annual General Meeting, May 06, 2013

Hansa Medical AB, Annual General Meeting, May 06, 2013.

Hansa Medical AB Reports Group Earnings Results for the Second Half and Full Year Ended December 31, 2011

Hansa Medical AB reported group earnings results for the second half and full year ended December 31, 2011. For the second half year, on group basis, the company reported net sales of SEK 882,433 against SEK 4,157,241 for the same period in the last year. Operating loss was SEK 14,075,335 against SEK 12,495,999 for the same period in the last year. Loss after financial items was SEK 14,030,169 against SEK 12,495,223 for the same period in the last year. Loss was SEK 14,030,234 against SEK 11,195,126 for the same period in the last year. Loss per share was SEK 1.04 against SEK 1.45 for the same period in the last year. For the year, on group basis, the company reported net sales of SEK 1,282,219 against SEK 4,448,186 for the same period in the last year. Operating loss was SEK 24,464,324 against SEK 19,992,855 for the same period in the last year. Loss after financial items was SEK 24,571,956 against SEK 20,143,336 for the same period in the last year. Loss was SEK 24,572,021 against SEK 18,843,239 for the same period in the last year. Loss per share was SEK 2.26 against SEK 2.44 for the same period in the last year. Cash flow from operating activities was SEK 27,139,111 against SEK 18,093,957 for the same period in the last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HMED:SS kr4.21 SEK -0.16

HMED Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HMED.
View Industry Companies
 

Industry Analysis

HMED

Industry Average

Valuation HMED Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 17.0x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 13.6x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANSA MEDICAL RESEARCH AB, please visit www.hansamedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.